PrTMS® has not been evaluated in clinical research studies to date. However, PeakLogic® plans to pursue studies evaluating use of the PrTMS® protocol for the treatment of major mental health and neurocognitive disorders, including human performance. PeakLogic® also hopes to pursue FDA-clearance of new products that may improve TMS therapy more broadly.

PeakLogic® plans to research the potential safety and efficacy of PrTMS® for a variety of conditions, including: